Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hagen Kulbe

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Cytokine & Growth Factor Reviews|October 4, 2012
The role of interleukin-6 in gynaecological malignanciesJermaine I G Coward, Hagen Kulbe
The International Journal of Developmental Biology|September 7, 2004
The chemokine network in cancer--much more than directing cell movementHagen Kulbe, Neil R Levinson, Fran Balkwill, et al.
Molecular Cancer Therapeutics|July 2, 2009
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cellsJoseph Kwong, Hagen Kulbe, Donald Wong, et al.
Cancer Research|November 17, 2005
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cellsHagen Kulbe, Thorsten Hagemann, Piotr W Szlosarek, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2019
Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulationFang Guo, Zhi Yang, Hagen Kulbe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Reproducibility of positive AGO score in predicting complete cytoreduction in recurrent low-grade ovarian cancersEmel Canaz, Elena I Braicu, Hagen Kulbe, et al.
Molecular Cancer Therapeutics|July 11, 2007
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesisThorsten Hagemann, Stephen C Robinson, Richard G Thompson, et al.
Cancers|June 28, 2023
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer PatientsWanja Kassuhn, Pedro R Cutillas, Mirjana Kessler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Vaccinia virus induces programmed necrosis in ovarian cancer cellsLynsey M Whilding, Kyra M Archibald, Hagen Kulbe, et al.
Cancer Research|January 20, 2007
The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cellsHagen Kulbe, Richard Thompson, Julia L Wilson, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Cytokine & Growth Factor Reviews|October 4, 2012
The role of interleukin-6 in gynaecological malignanciesJermaine I G Coward, Hagen Kulbe
The International Journal of Developmental Biology|September 7, 2004
The chemokine network in cancer--much more than directing cell movementHagen Kulbe, Neil R Levinson, Fran Balkwill, et al.
Molecular Cancer Therapeutics|July 2, 2009
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cellsJoseph Kwong, Hagen Kulbe, Donald Wong, et al.
Cancer Research|November 17, 2005
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cellsHagen Kulbe, Thorsten Hagemann, Piotr W Szlosarek, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2019
Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulationFang Guo, Zhi Yang, Hagen Kulbe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Reproducibility of positive AGO score in predicting complete cytoreduction in recurrent low-grade ovarian cancersEmel Canaz, Elena I Braicu, Hagen Kulbe, et al.
Molecular Cancer Therapeutics|July 11, 2007
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesisThorsten Hagemann, Stephen C Robinson, Richard G Thompson, et al.
Cancers|June 28, 2023
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer PatientsWanja Kassuhn, Pedro R Cutillas, Mirjana Kessler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Vaccinia virus induces programmed necrosis in ovarian cancer cellsLynsey M Whilding, Kyra M Archibald, Hagen Kulbe, et al.
Cancer Research|January 20, 2007
The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cellsHagen Kulbe, Richard Thompson, Julia L Wilson, et al.
Pageof 6